news about tirzepatide The US-FDA has approved for chronic weight management in adults with Obesity - Study links semaglutide and tirzepatide

Afr Health Sci

Medical Disclaimer The information on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment

In conclusion, the study found that semaglutide, in combination with lifestyle intervention, was associated with a sustained and clinically relevant reduction in body weight in individuals with overweight or obesity

Horn et al., 2022

This means that both the onset of full effect when starting treatment and the waning of effect when stopping treatment may take several weeks

Genetic Predispositions in GLP-1 Receptor Pathways and Treatment Context Individual genetic variants in the GLP1R gene and related metabolic pathwayssuch as GLP1R rs6923761 and GIPR rs1800437create natural variation in how bodies respond to GLP-1 receptor activation